The Effect of Cancer Awareness Web-Based Education in Schools

June 1, 2026 updated by: Fatma Şeyda Özbıçakcı, Dokuz Eylul University

The Effect of Web-Based Cancer Awareness Education in Schools on Students' Knowledge Level, Help-Seeking Behaviors, and Stigma Attitudes

Objective: This study aims to determine the effect of web-based cancer awareness education in schools on students' knowledge levels, help-seeking attitudes, and stigma attitudes.

Method: The Web-Based Adolescent Cancer Education (WAKE) study was planned as a school-based, randomized controlled experimental study. Qualified high schools in the public sector of Izmir province will constitute the study population. Private schools are excluded for adolescents whose additional needs cannot be met in inclusive education. Two schools will be selected using a purposive sampling method (15-18 age group) and assigned to the experimental and control groups. This will prevent interaction between students in both schools. Students in each school will be listed, and assignments to groups will be made using a web-based randomizer application with randomly selected numbers (https://www.randomizer.org/). Data will be collected using the Cancer Awareness Scale (CAM), the Cancer Stigma Scale (CASS-T), and a Basic Demographic Questionnaire. In the evaluation of the data, descriptive statistics (number, percentage, and statistic) will be used, and repeated measures analysis of variance will be employed to assess the effect of the intervention. Differences in results between the experimental and control groups will be tested using multiple regression methods.

Study Overview

Status

Active, not recruiting

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Being a student aged 15-18 in selected schools
  • Volunteers who have withdrawn must agree to participate
  • Parents must fill out an informed consent form
  • Lack of literacy skills

Exclusion Criteria:

  • Having a problem that will prevent communication
  • Students who do not agree to the study
  • Students whose parents' permission cannot be obtained
  • Not being able to access and use the internet
  • The student wants to voluntarily withdraw from the research

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Web-Based Cancer Awareness Education
Students receive a web-based cancer awareness education program delivered in school settings, providing education on cancer awareness, help-seeking behaviors, and cancer-related stigma.
Behavioral: Web-Based Cancer Awareness Education
A web-based educational program delivered in school settings that provides education on cancer-related knowledge, help-seeking behaviors, and cancer-related stigma.
No Intervention: No Cancer Awareness Education Control
Students do not receive the web-based cancer awareness education program during the study period.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cancer Awareness Level
Time Frame: Baseline (pre-intervention), immediately after the intervention, 1 month after the intervention, and 3 months after the intervention.
Cancer Awareness Level: Cancer awareness will be assessed using the Cancer Awareness Measure (CAM). The CAM measures multiple dimensions of cancer awareness, including awareness of cancer warning signs, cancer risk factors, and help-seeking behavior. Total scores range from 0 to 77, with higher scores indicating greater cancer awareness.
Baseline (pre-intervention), immediately after the intervention, 1 month after the intervention, and 3 months after the intervention.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cancer-Related Stigma Attitudes
Time Frame: Baseline (pre-intervention), immediately after the intervention, 1 month after the intervention, and 3 months after the intervention.
Cancer-related stigma attitudes will be assessed using the Cancer Stigma Scale-Turkish (CASS-T). The scale measures attitudes toward individuals with cancer and cancer-related stigma. Total scores range from 25 to 150, with higher scores indicating greater perceived stigma.
Baseline (pre-intervention), immediately after the intervention, 1 month after the intervention, and 3 months after the intervention.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Dokuz Eylul University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2026

Primary Completion (Estimated)

June 1, 2026

Study Completion (Estimated)

June 1, 2026

Study Registration Dates

First Submitted

May 22, 2026

First Submitted That Met QC Criteria

May 22, 2026

First Posted (Actual)

May 29, 2026

Study Record Updates

Last Update Posted (Actual)

June 3, 2026

Last Update Submitted That Met QC Criteria

June 1, 2026

Last Verified

June 1, 2026

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • Institute of Health Sciences

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cancer Awareness and Prevention Education

Clinical Trials on Web-Based Cancer Awareness Education

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Sri Lanka

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe